Nan Sheng

Dr. Nan Sheng

College of Computer Science and Technology, JilinUniversity, Changchun, Jilin, China
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
NSNan Sheng
Nan Sheng
YWYan Wang
Yan Wang
LHLan Huang
Lan Huang
LGLing Gao
Ling Gao
YCYangkun Cao
Yangkun Cao
YFYuan Fu
Yuan Fu
Motivation: Identifying the relationships among long non-coding RNAs (lncRNAs), microRNAs (miRNAs) and diseases is highly valuable for diagnosing, preventing, treating and prognosing diseases. The development of effective computational prediction methods can reduce experimental costs. While numerous methods have been proposed, they often to treat the prediction of lncRNA-disease associations (LDAs), miRNA-disease associations (MDAs) and lncRNA-miRNA interactions (LMIs) as separate task. Models capable of predicting all three relationships simultaneously remain relatively scarce. Our aim is to perform multi-task predictions, which not only construct a unified framework, but also facilitate mutual complementarity of information among lncRNAs, miRNAs and diseases.Results: In this work, we propose a novel unsupervised embedding method called graph contrastive learning for multi-task prediction (GCLMTP). Our approach aims to predict LDAs, MDAs and LMIs by simultaneously extracting embedding representations of lncRNAs, miRNAs and diseases. To achieve this, we first construct a triple-layer lncRNA–miRNA-disease heterogeneous graph (LMDHG) that integrates the complex relationships between these entities based on their similarities and correlations. Next, we employ an unsupervised embedding model based on graph contrastive learning to extract potential topological feature of lncRNAs, miRNAs and diseases from the LMDHG. The graph contrastive learning leverages graph convolutional network architectures to maximize the mutual information between patch representations and corresponding high-level summaries of the LMDHG. Subsequently, for the three prediction tasks, multiple classifiers are explored to predict LDA, MDA and LMI scores. Comprehensive experiments are conducted on two datasets (from older and newer versions of the database, respectively). The results show that GCLMTP outperforms other state-of-the-art methods for the disease-related lncRNA and miRNA prediction tasks. Additionally, case studies on two datasets further demonstrate the ability of GCLMTP to accurately discover new associations. To ensure reproducibility of this work, we have made the datasets and source code publicly available at https://github.com/sheng-n/GCLMTP.

20 November 2020 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
PXPing Xuan
Ping Xuan
LGLing Gao
Ling Gao
NSNan Sheng
Nan Sheng
TZTiangang Zhang
Tiangang Zhang
TNToshiya Nakaguchi
Toshiya Nakaguchi
Predicting novel uses for approved drugs helps in reducing the costs of drug development and facilitates the development process. Most of previous methods focused on the multi-source data related to drugs and diseases to predict the candidate associations between drugs and diseases. There are multiple kinds of similarities between drugs, and these similarities reflect how similar two drugs are from the different views, whereas most of the previous methods failed to deeply integrate these similarities. In addition, the topology structures of the multiple drug-disease heterogeneous networks constructed by using the different kinds of drug similarities are not fully exploited. We therefore propose GFPred, a method based on a graph convolutional autoencoder and a fully-connected autoencoder with an attention mechanism, to predict drug-related diseases. GFPred integrates drug-disease associations, disease similarities, three kinds of drug similarities and attributes of the drug nodes. Three drug-disease heterogeneous networks are constructed based on the different kinds of drug similarities. We construct a graph convolutional autoencoder module, and integrate the attributes of the drug and disease nodes in each network to learn the topology representations of each drug node and disease node. As the different kinds of drug attributes contribute differently to the prediction of drug-disease associations, we construct an attribute-level attention mechanism. A fully-connected autoencoder module is established to learn the attribute representations of the drug and disease nodes. Finally, the original features of the drug-disease node pairs are also important auxiliary information for their association prediction. A combined strategy based on a convolutional neural network is proposed to fully integrate the topology representations, the attribute representations, and the original features of the drug-disease pairs. The ablation studies showed the contributions of data related to three types of drug attributes. Comparison with other methods confirmed that GFPred achieved better performance than several state-of-the-art prediction methods. In particular, case studies confirmed that GFPred is able to retrieve more actual drug-disease associations in the top k part of the prediction results. It is helpful for biologists to discover real associations by wet-lab experiments.

20 May 2020 in Briefings in Bioinformatics
Verified
Journal Article
Closed access
NSNan Sheng
Nan Sheng
HCHui Cui
Hui Cui
TZTiangang Zhang
Tiangang Zhang
PXPing Xuan
Ping Xuan
As the abnormalities of long non-coding RNAs (lncRNAs) are closely related to various human diseases, identifying disease-related lncRNAs is important for understanding the pathogenesis of complex diseases. Most of current data-driven methods for disease-related lncRNA candidate prediction are based on diseases and lncRNAs. Those methods, however, fail to consider the deeply embedded node attributes of lncRNA–disease pairs, which contain multiple relations and representations across lncRNAs, diseases and miRNAs. Moreover, the low-dimensional feature distribution at the pairwise level has not been taken into account. We propose a prediction model, VADLP, to extract, encode and adaptively integrate multi-level representations. Firstly, a triple-layer heterogeneous graph is constructed with weighted inter-layer and intra-layer edges to integrate the similarities and correlations among lncRNAs, diseases and miRNAs. We then define three representations including node attributes, pairwise topology and feature distribution. Node attributes are derived from the graph by an embedding strategy to represent the lncRNA–disease associations, which are inferred via their common lncRNAs, diseases and miRNAs. Pairwise topology is formulated by random walk algorithm and encoded by a convolutional autoencoder to represent the hidden topological structural relations between a pair of lncRNA and disease. The new feature distribution is modeled by a variance autoencoder to reveal the underlying lncRNA–disease relationship. Finally, an attentional representation-level integration module is constructed to adaptively fuse the three representations for lncRNA–disease association prediction. The proposed model is tested over a public dataset with a comprehensive list of evaluations. Our model outperforms six state-of-the-art lncRNA–disease prediction models with statistical significance. The ablation study showed the important contributions of three representations. In particular, the improved recall rates under different top $k$ values demonstrate that our model is powerful in discovering true disease-related lncRNAs in the top-ranked candidates. Case studies of three cancers further proved the capacity of our model to discover potential disease-related lncRNAs.

2 January 2023 in Computers in Biology and Medicine
Verified
Journal Article
Open access
NSNan Sheng
Nan Sheng
LHLan Huang
Lan Huang
YLYuting Lu
Yuting Lu
HWHao Wang
Hao Wang
LYLili Yang
Lili Yang
YWYan Wang
Yan Wang
Increasing interest has been attracted in deciphering the potential disease pathogenesis through lncRNA-disease association (LDA) prediction, regarding to the diverse functional roles of lncRNAs in genome regulation. Whilst, computational models and algorithms benefit systematic biology research, even facilitate the classical biological experimental procedures. In this review, we introduce representative diseases associated with lncRNAs, such as cancers, cardiovascular diseases, and neurological diseases. Current publicly available resources related to lncRNAs and diseases have also been included. Furthermore, all of the 64 computational methods for LDA prediction have been divided into 5 groups, including machine learning-based methods, network propagation-based methods, matrix factorization- and completion-based methods, deep learning-based methods, and graph neural network-based methods. The common evaluation methods and metrics in LDA prediction have also been discussed. Finally, the challenges and future trends in LDA prediction have been discussed. Recent advances in LDA prediction approaches have been summarized in the GitHub repository at https://github.com/sheng-n/lncRNA-disease-methods.

Verified
Journal Article
Open access
PDF file
PXPing Xuan
Ping Xuan
NSNan Sheng
Nan Sheng
TZTiangang Zhang
Tiangang Zhang
YLYong Liu
Yong Liu
YGYahong Guo
Yahong Guo
It is well known that the unusual expression of long non-coding RNAs (lncRNAs) is closely related to the physiological and pathological processes of diseases. Therefore, inferring the potential lncRNA–disease associations are helpful for understanding the molecular pathogenesis of diseases. Most previous methods have concentrated on the construction of shallow learning models in order to predict lncRNA-disease associations, while they have failed to deeply integrate heterogeneous multi-source data and to learn the low-dimensional feature representations from these data. We propose a method based on the convolutional neural network with the attention mechanism and convolutional autoencoder for predicting candidate disease-related lncRNAs, and refer to it as CNNDLP. CNNDLP integrates multiple kinds of data from heterogeneous sources, including the associations, interactions, and similarities related to the lncRNAs, diseases, and miRNAs. Two different embedding layers are established by combining the diverse biological premises about the cases that the lncRNAs are likely to associate with the diseases. We construct a novel prediction model based on the convolutional neural network with attention mechanism and convolutional autoencoder to learn the attention and the low-dimensional network representations of the lncRNA–disease pairs from the embedding layers. The different adjacent edges among the lncRNA, miRNA, and disease nodes have different contributions for association prediction. Hence, an attention mechanism at the adjacent edge level is established, and the left side of the model learns the attention representation of a pair of lncRNA and disease. A new type of lncRNA similarity and a new type of disease similarity are calculated by incorporating the topological structures of multiple bipartite networks. The low-dimensional network representation of the lncRNA-disease pairs is further learned by the autoencoder based convolutional neutral network on the right side of the model. The cross-validation experimental results confirm that CNNDLP has superior prediction performance compared to the state-of-the-art methods. Case studies on stomach cancer, breast cancer, and prostate cancer further show the ability of CNNDLP for discovering the potential disease lncRNAs.

16 September 2024 in Artificial Intelligence Review
Verified
Journal Article
Open access
PDF file
YWYan Wang
Yan Wang
WHWenju Hou
Wenju Hou
NSNan Sheng
Nan Sheng
ZZZiqi Zhao
Ziqi Zhao
JLJialin Liu
Jialin Liu
JWJuexin Wang
Juexin Wang
Graph neural networks (GNNs) process the graph-structured data using neural networks and have proven successful in various graph processing tasks. Currently, graph pooling operators have emerged as crucial components that bridge the gap between node representation learning and diverse graph-level tasks by transforming node representations into graph representations. Given the rapid growth and widespread adoption of graph pooling, this review aims to summarize the existing graph pooling operators for GNNs and their representative applications in omics. Specifically, we first present a comprehensive taxonomy of existing graph pooling algorithms, expanding the categorization for both global and hierarchical pooling operators, and for the first time reviewing the inverse operation of graph pooling, named unpooling. Next, we describe the general evaluation framework for graph pooling operators, encompassing three fundamental aspects: experimental setup, ablation analysis, and model interpretation. We also discuss open issues that significantly influence the design of graph pooling operators, including complexity, connectivity, adaptability, additional loss, and attention mechanisms. Finally, we summarize bioinformatics applications of graph pooling operators in omics, including graphs of gene interaction, medical images, and protein structures for drug discovery and disease diagnosis. Furthermore, we showcase the impact of graph pooling operators on research in specific real-world domains, with a focus on prediction performance and model interpretability. This review provides methodological insights in machine learning based graph modeling and related omics research, as well as an ongoing resource by gathering related papers and code in a dedicated GitHub repository (https://github.com/Hou-WJ/Graph-Pooling-Operators-and-Bioinformatics-Applications).